会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • VASODIALATING DRESSING FOR USE WITH INTRAVENOUS CATHETERS
    • VASODIALATING DRESSING用于内窥镜
    • WO2007124110A2
    • 2007-11-01
    • PCT/US2007/009756
    • 2007-04-19
    • CURE THERAPEUTICS, INC.ANG, RobertGELIEBTER, David
    • ANG, RobertGELIEBTER, David
    • A61L15/00A61K31/21
    • A61L15/44A61K31/21A61L15/58A61L2300/204A61L2300/40A61L2300/602
    • The present invention is drawn to adhesive dressings and associated systems and methods for use in reducing the occurrence of phlebitis and extending the lifespan of intravenous catheters. The adhesive dressings can include a backing layer, and a nitroglycerin-containing composition supported at least in part by the backing layer. The adhesive dressing can have a drug delivery zone defined by the area where the nitroglycerin-containing composition contacts an intact human skin site. The drug delivery zone can have an area of at least 2.5 cm 2 and can be configured such that when the adhesive dressing is applied to secure an intravenous catheter the drug delivery zone substantially overlays a vessel in which the intravenous catheter is inserted. The nitroglycerin-containing composition can be formulated to deliver nitroglycerin at from about 5 μg/hour to about 80 μg/hour.
    • 本发明涉及用于减少静脉炎发生并延长静脉内导管的寿命的粘合剂敷料和相关系统和方法。 粘合剂敷料可以包括背衬层和至少部分由背衬层支撑的含有硝酸甘油的组合物。 粘合敷料可以具有由含硝酸甘油的组合物接触完整的人皮肤部位的区域限定的药物递送区域。 药物递送区可以具有至少2.5cm 2的面积,并且可以被配置为使得当施加粘合剂敷料以固定静脉内导管时,药物递送区基本上覆盖其中静脉内 插入导管。 含硝酸甘油的组合物可配制成以约5μg/小时至约80μg/小时递送硝酸甘油。
    • 7. 发明申请
    • VASODIALATING DRESSING FOR USE WITH INTRAVENOUS CATHETERS
    • VASODIALATING DRESSING用于内窥镜
    • WO2007124110A3
    • 2008-12-04
    • PCT/US2007009756
    • 2007-04-19
    • CURE THERAPEUTICS INCANG ROBERTGELIEBTER DAVID
    • ANG ROBERTGELIEBTER DAVID
    • A61F13/02A61F13/00A61M29/00
    • A61L15/44A61K31/21A61L15/58A61L2300/204A61L2300/40A61L2300/602
    • The present invention is drawn to adhesive dressings and associated systems and methods for use in reducing the occurrence of phlebitis and extending the lifespan of intravenous catheters. The adhesive dressings can include a backing layer, and a nitroglycerin-containing composition supported at least in part by the backing layer. The adhesive dressing can have a drug delivery zone defined by the area where the nitroglycerin-containing composition contacts an intact human skin site. The drug delivery zone can have an area of at least 2.5 cm2 and can be configured such that when the adhesive dressing is applied to secure an intravenous catheter the drug delivery zone substantially overlays a vessel in which the intravenous catheter is inserted. The nitroglycerin-containing composition can be formulated to deliver nitroglycerin at from about 5 µg/hour to about 80 µg/hour.
    • 本发明涉及用于减少静脉炎发生并延长静脉内导管的寿命的粘合剂敷料和相关系统和方法。 粘合剂敷料可以包括背衬层和至少部分由背衬层支撑的含有硝酸甘油的组合物。 粘合敷料可以具有由含硝酸甘油的组合物接触完整的人皮肤部位的区域限定的药物递送区域。 药物递送区可以具有至少2.5cm 2的面积,并且可以构造成使得当施加粘合剂敷料以固定静脉内导管时,药物递送区基本上覆盖其中插入静脉内导管的血管。 含硝酸甘油的组合物可配制成以约5μg/小时至约80μg/小时递送硝酸甘油。
    • 9. 发明申请
    • Low dose no donor-containing transdermal patch
    • 低剂量无供体透皮贴剂
    • US20070202155A1
    • 2007-08-30
    • US11701964
    • 2007-02-01
    • Robert AngLudwig WeimannSven Jacobson
    • Robert AngLudwig WeimannSven Jacobson
    • A61K9/70A61K31/21
    • A61K9/7061A61K31/21A61K47/10
    • The present invention is drawn to a transdermal patch for the delivery of a nitroglycerin or other NO donor. The patch can comprise a backing layer, and a nitroglycerin-containing composition or other NO donor-containing composition which is supported at least in part by the backing layer. The transdermal patch can have a drug delivery zone defined by the area where the composition contacts an intact human skin site, and the transdermal patch can be formulated to deliver a nitric oxide donor, such as nitroglycerin, at from about 5 μg/hour to about 70 μg/hour. In one embodiment, the transdermal patch can provide a delivery rate at the drug delivery zone of from about 1 μg/cm2/day to about 600 μg/cm2/day. In another embodiment, the transdermal patch can contain from 6 wt % to 18 wt % of the nitric oxide donor, e.g., nitroglycerin. In each embodiment, the patch can contain at least 450 μg/cm2 of nitroglycerin.
    • 本发明涉及用于递送硝酸甘油或其他NO供体的透皮贴片。 贴片可以包含背衬层和含硝酸甘油的组合物或其它含NO供体的组合物,其至少部分由背衬层支撑。 透皮贴剂可以具有由组合物接触完整的人皮肤部位的区域限定的药物递送区,并且透皮贴剂可以配制成以约5mug /小时至约约5ug /小时递送一氧化氮供体,例如硝酸甘油 70杯/小时。 在一个实施方案中,透皮贴剂可以在药物递送区域提供约1mug / cm 2 /天至约600mug / cm 2 /天的输送速率 。 在另一个实施方案中,透皮贴剂可含有6重量%至18重量%的一氧化氮供体,例如硝酸甘油。 在每个实施方案中,贴片可以含有至少450杯/平方厘米的硝酸甘油。